Method of implanting a subcutaneous defibrillator

• US 8,090,438 B2
• Filed: 05/17/2010
• Issued: 01/03/2012
• Est. Priority Date: 09/18/2000
• Status: Expired due to Fees

• Current Assignee: Cameron Health Inc (Boston Scientific Corporation)
• Original Assignee: Cameron Health Inc (Boston Scientific Corporation)
• Inventors: Cappato, Riccardo, Bardy, Gust H.
• Primary Examiner(s): Gedeon, Brian T
• Application Number:
  US12/781,668
• Publication Number:
  US 20100228306A1
• Time in Patent Office: 596 Days
• Field of Search: 607/2, 607/4, 607/5, 607/119, 128/898
• US Class Current: 607/5
• CPC Class Codes: A61B 5/283 Invasive
• CPC Class Codes: A61B 5/29 for permanent or long-term implantation
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

A subcutaneous implantable cardioverter-defibrillator is disclosed which has an electrically active canister which houses a source of electrical energy, a capacitor, and operational circuitry that senses the presence of potentially fatal heart rhythms. At least one subcutaneous electrode that serves as the opposite electrode from the canister is attached to the canister via a lead system. Cardioversion-defibrillation energy is delivered when the operational circuitry senses a potentially fatal heart rhythm. There are no transvenous, intracardic, or epicardial electrodes. A method of subcutaneously implanting the cardioverter-defibrillator is also disclosed as well as a kit for conducting the method.

Claims

1. A method of implanting an implantable defibrillator in a patient, the implantable defibrillator comprising a canister and a lead, the method comprising:

making an incision in the left anterior axillary line;

creating a subcutaneous pathway for implantation of the canister medially of the incision and creating a canister location at approximately the left inframammary crease;

creating a subcutaneous pathway for implantation of the lead posteriorly from the incision toward the left posterior axillary line using a curved trocar;

developing the subcutaneous pathway for implantation of the lead such that it terminates at a point that, if a straight line were drawn from the canister location to the termination point, the line would intersect a substantial portion of the left ventricular mass of the patient;

inserting the lead into the subcutaneous pathway for implantation of the lead; and

placing the canister medially of the incision at the canister location.

2. The method of claim 1 wherein the step of developing the subcutaneous pathway for implantation of the lead comprises, after creating the subcutaneous pathway for implantation of the lead with the curved trocar,

inserting guidewire through the trocar;

removing the curved trocar and leaving the guidewire in place;

inserting a stiff curved peel away sheath over the guidewire; and

removing the guidewire.

3. The method of claim 2 wherein the step of inserting the lead is performed by:

inserting the lead into the stiff curved peel away sheath after the guidewire is removed; and

splitting and removing the stiff curved peel away sheath.

4. The method of claim 3 wherein the lead comprises a distal end and a proximal end, the proximal end adapted for coupling to the canister, wherein the distal end comprises an anchor segment for anchoring into tissue such that the lead does not dislodge after implantation, wherein the method is performed such that the anchor segment is emplaced to the termination point.

5. The method of claim 4 wherein the anchor segment comprises a tine.

6. The method of claim 4 wherein the anchor segment comprises a screw.

7. The method of claim 4 wherein the anchor segment comprises a hook.

8. The method of claim 3 wherein the lead comprises a distal end and a proximal end, the proximal end adapted for coupling to the canister, wherein the distal end comprises a means for anchoring the lead into tissue such that the lead does not dislodge after implantation, wherein the method is performed such that the distal end is emplaced to the termination point.

9. The method of claim 1 wherein the trocar includes a lumen and the method further comprises injecting a fluid via the lumen during the step of creating a subcutaneous pathway for implantation of the lead.

10. The method of claim 1 wherein the lead comprises a distal end and a proximal end, the proximal end adapted for coupling to the canister, wherein the distal end comprises an anchor segment for anchoring into tissue such that the lead does not dislodge after implantation, wherein the method is performed such that the anchor segment is emplaced to the termination point.

11. The method of claim 10 wherein the anchor segment comprises a tine.

12. The method of claim 10 wherein the anchor segment comprises a screw.

13. The method of claim 10 wherein the anchor segment comprises a hook.

14. The method of claim 1 wherein the lead comprises a distal end and a proximal end, the proximal end adapted for coupling to the canister, wherein the distal end comprises means for anchoring the lead into tissue such that the lead does not dislodge after implantation, wherein the method is performed such that the distal end is emplaced to the termination point.

15. The method of claim 1 wherein the implantable defibrillator further comprises a second lead and the method further comprises:

creating a subcutaneous pathway for implantation of the second lead posteriorly from the incision to the left posterior axillary line; and

inserting the second lead into the subcutaneous pathway for implantation of the second lead.

16. The method of claim 15 further comprising:

developing the subcutaneous pathway for implantation of the second lead such that it terminates at a point that, if a straight line were drawn from the canister location to the termination point, the line would intersect a substantial portion of the left ventricular mass of the patient.

17. The method of claim 16 wherein each of the leads comprise a distal end and a proximal end, the proximal end adapted for coupling to the canister, wherein the distal end comprises an anchor segment for anchoring into tissue such that the lead does not dislodge after implantation.

18. The method of claim 16 wherein:

each of the leads comprises a distal end and a proximal end,

for each lead, the proximal end is adapted for coupling to the canister; and

each lead comprises means for anchoring the distal end of each respective lead into tissue such that the lead does not dislodge after implantation.

19. A method of implanting an implantable defibrillator, the implantable defibrillator comprising a canister and a lead, the method comprising:

making an anterior incision on a patient'"'"'s ribcage;

creating a space adjacent the anterior incision near the left inframammary crease of the patient for implantation of the canister;

creating a subcutaneous pathway from the incision posteriorly to the left posterior axillary line for implantation of the lead using at least a trocar and a peel away sheath;

leaving the peel away sheath in the subcutaneous pathway for implantation of the lead;

implanting the lead through the peel away sheath;

removing the peel away sheath; and

implanting the canister in the space for implantation of the canister;

wherein the lead has a proximal end adapted for coupling to the canister and a distal end, and the lead comprises a means for anchoring the distal end of the lead to maintain a posterior position of the lead.

20. The method of claim 19 wherein the step of creating a subcutaneous pathway for implantation of the lead comprises:

inserting the trocar through the incision while injecting an anesthetic through a lumen of the trocar;

inserting a guidewire through the trocar;

removing the trocar; and

advancing the peel away sheath over the guidewire;

wherein the peel away sheath is a stiff curved peel away sheath; and

wherein the step of leaving the peel away sheath in the subcutaneous pathway for implantation of the lead comprises removing the guidewire.